Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Caranx Medical TAVIPILOT

FDA clears AI-powered software for real-time TAVR guidance

Caranx Medical is focused on using AI, robotics and other advanced technologies to expand patient access to life-saving procedures. This new software, for example, helps guide cardiologists through complex TAVR procedures.

vitamin d supplement heart health CVD

Yes, researchers argue, vitamin D supplements help protect the heart

The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.

Doctor accused of forging vaccine cards and injecting children with saline has all charges dropped

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

foot feet podiatry podiatrist

Doppler ultrasound offers accurate, accessible alternative for diagnosing peripheral artery disease

Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Update to Johnson & Johnson PFA platform gains FDA approval

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

Ultromics EchoGo Amyloidosis artificial intelligence

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

Bayer finerenone Kerendia heart failure MOONRAKER

FDA approves Bayer's finerenone to treat wide range of heart failure patients

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.